All
“Life…supplemented” Study Reveals Doctor's Supplement Choices
December 11th 2008The results of the 2008 “Life…supplemented” Healthcare Professionals Impact Study show that orthopedic specialists, cardiologists and dermatologists both consume and give dietary supplements to their patients for nuanced diseases as well as overall wellness.
Nordic Naturals Defends Cod Liver Oil In Light of Vitamin A Study
December 4th 2008Nordic Naturals (Watsonville, CA) defended its cod liver oil products as posing no threat to consumers, the company said on December 1, in light of a report suggesting cod liver oil may be detrimental to humans due to its high vitamin A content.
Vitamin D Intake to Come from Diet & Supplements, Advises AAD
December 4th 2008The American Academy of Dermatology (Schaumburg, IL) issued a statement on December 4 advising the public to obtain vitamin D from their diet and dietary supplements, rather than exposing themselves to UV radiation from the sun.
Ecuadorian Rainforest to Host Webinar
November 18th 2008Ecuadorian Rainforest’s (Belleville, NJ) vice president of marketing, Steve Siegel, will conduct a “Nutraceuticals 2009” webinar on December 11th, 2008 at 2:00pm. The seminar will look at “a new year full of new ingredients, new trends and an ever changing economy,” the company said.
InterHealth Receives ISO Certification
November 14th 2008InterHealth Nutraceuticals (Benicia, CA) has received its ISO 9001:2000 certification, the company announced on November 14.An ISO certification provides assurance on good management practice by an independent body.\"Our customers see a real benefit in the quality of our products and services and ability to respond efficiently to their need,\" said Paul Dijkstra, InterHealth CEO.InterHealth\'s ingredients are used in over 600 nutritional supplements, functional foods and beverages distributed in more than 30 countries worldwide.
Vitamins C and E Not Beneficial in Heart Disease Prevention, Study Concludes
November 10th 2008Vitamins C and E were not effective in preventing cardiovascular disease in males, concluded the Physician’s Health Study II that will be published in the November 12 issue of the Journal of the American Medical Association.
Fortitech Launches New Initiative to Battle Malnutrition
November 4th 2008Helping support the battle against global malnutrition, Fortitech Inc. (Schenectady, NY) announced the launch of the World Initiative for Nutrition (WIN) on November 4. WIN will work with governmental and non-governmental organizations, ingredient suppliers, local food mills and manufacturers to develop and deliver tailored nutritional solutions.
FDA Issues Warning Letters to Bayer HealthCare
October 29th 2008On October 28, two of Bayer HealthCare’s (Leverkusen, Germany) over-the-counter products were met with warning letters from FDA (Rockville, MD). Two of the company’s OTC aspirin products - Bayer Women\'s Low Dose Aspirin + Calcium (Bayer Women\'s) and Bayer Aspirin with Heart Advantage (Bayer Heart Advantage) - require “new drug application” in order to be marketed legally.
No Benefit from Selenium and Vitamin E Supplements, Concludes Prostate Cancer Prevention Study
October 27th 2008Selenium and vitamin E supplements, used together or separately, did not prevent prostate cancer, concluded a review of data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), funded by the National Cancer Institute (NCI; Rockville, MD).
BASF to Present S.E.T. Initiative at Supply Side West
October 20th 2008BASF Corporation (Florham Park, NJ), the American base of the German-based chemical company, will present the S.E.T. (Sustainability, Eco-Efficiency, and Traceability) Initiative, in a VendorWorks session at the Supply Side West Conference.
Deal Signed Between Frutarom USA, BLIS K12
October 17th 2008BLIS Technologies Ltd. (Dunedin, New Zealand), developer of BLIS K12, a probiotic for upper airways infection prevention such as bacterial sore throats, tooth and gum disease and chronic bad breath, announced on October 17 that it had signed a distribution agreement with Frutarom, USA (North Bergen, NJ).
ChromaDex Obtains Additional Working Capital
September 29th 2008ChromaDex Corp. (Irvine, CA) raised $4.2 million through a private placement stock offering that began in March, the company said on August 8. New Castle Financial Services (New York City) acted as the private placement agent for the transaction, which yielded gross proceeds of $4.67 million.
NAI Sells Catalog and Internet Business
September 29th 2008Natural Alternatives International (NAI; San Marcos, CA) sold its As We Change catalog and Internet business for $2 million in cash, the company announced on August 5.The sale of the catalog business, operated by NAI’s wholly owned subsidiary Real Health Laboratories Inc., will enable NAI to concentrate on its private label and contract manufacturing clients.
USP Opens New Brazilian Facility
September 29th 2008The U.S. Pharmacopeia (Rockville, MD) opened a new, 1800-sq-meter facility in the Wtorre Technology Park in Sao Paulo, Brazil, on August 18. The facility, situated close to several of USP’s pharmaceutical clients, contains state-of-the-art office and laboratory space that the organization will use to dispense its publications and reference standards to local manufacturers.
Cognis Achieves NSF Certification
September 29th 2008Cognis Nutrition & Health received good manufacturing practices (GMPs) registration for its Covtiol vitamin E, Vegapure phytosterol, and Tonalin conjugated linoleic acid ingredients, the company announced on August 4. NSF International (Ann Arbor, MI) awarded the certification to Cognis’ production facilities in Kankakee, IL, and Illertissen, Germany, after conducting an intensive plant audit. NSF also will conduct periodic audits in the future.
What Can You Say When You Can’t Say Anything?
September 7th 2008You're excited, and elated. Clinical trials have proven conclusively that your new product works . It's like being in love-you want to shout it from the rooftops! You've developed a dietary supplement that will really help people with anemia, or arthritis, or obesity, or macular degeneration.